1 Magnificent S&P 500 Dividend Stock Down 56% to Buy and Hold Forever

Given its key role in the fight against COVID-19, the fact that Pfizer (PFE 0.11%) shares are down 56% from their 2021 peak isn't entirely surprising. Demand for its COVID-19 vaccine (Comirnaty) and its treatment (Paxlovid) soared during the pandemic's height. With the coronavirus contagion abating in the meantime, though, last year's sales fell 41%. Income fell more than 70% year over year. Yikes.However, the stock's sellers have arguably overshot their target. Pfizer stock is not only now well undervalued ...